Cipla enters into joint venture agreement with Kemwell Biopharma

25 Aug 2021 Evaluate

Cipla has entered into a joint venture agreement with Kemwell Biopharma on August 25, 2021 for incorporation of a joint venture company for undertaking the business of developing, applying for and obtaining licenses for and manufacturing, commercialising, importing and exporting biologic products and licensing or outsourcing of any or all such activities. The JV Company is being incorporated with an objective to enter the respiratory biosimilars space.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1491.40 -3.00 (-0.20%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×